Health product recall

Semaglutide Injection : Out-of-Specification (Impurity)

Last updated

Summary

Product
Semaglutide Injection
Issue
Health products - Product quality
What to do

Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot Number

Dr. Reddy's Laboratories Canada Inc

Semaglutide Injection

DIN 02567806

Solution

Semaglutide 1.34 mg/ml

7000544,
7000545,
7000546

Dr. Reddy's Laboratories Canada Inc

Semaglutide Injection

DIN 02567814

Solution

Semaglutide 1.34 mg/ml

7000542,
7000543,
7000624,
7000628,
7000629

Issue

An impurity is out of specification in all lots of the affected products.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of Recall: Retaillers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Recalling Firm
Dr. Reddy's Laboratories Canada Inc.  
5580 Explorer Dr, Suite 204 
Mississauga,ON L4W 4Y1

Market Authorization Holder
DR REDDY'S LABORATORIES LTD
Survey Nos. 42, 45, 46 & 54, Innovation Plaza, Bachupally
Medchal-Malkajgiri
Telangana
India 500090

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-82537

Get notified

Receive emails about new and updated recall and safety alerts.

Subscribe